ACET

Adicet Bio, (ACET)

About Adicet Bio, (ACET)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Details

Daily high

$0.93

Daily low

$0.88

Price at open

$0.91

52 Week High

$3.62

52 Week Low

$0.81

Market cap

74.9M

Dividend yield

0.00%

Volume

215,836

Avg. volume

477,478

P/E ratio

-.53

Adicet Bio, News